The MattCorc Podcast

A $500 Million Biotech IPO. Amarin Data


Listen Later

Moderna plans the biggest biotech IPO ever and we learn more about Amarin’s clinical study. Was mineral oil the best choice of placebo? Lessons we can learn from Amarin about D&O insurance.
...more
View all episodesView all episodes
Download on the App Store

The MattCorc PodcastBy Life Sciences Rush Hour - Inve